The latest news updates from the 2024 Symposium
Ines Vaz-Luis, MD, PhD, previews a Wednesday afternoon presentation on the future of digital interventions in the care of patients with breast cancer.
Lev Becker, PhD, previews a Wednesday afternoon presentation on neutrophil elastase and anti-tumor effects.
Ann H. Partridge, MD, MPH, will moderate a session on Wednesday looking at digital health solutions and patient reported outcomes to improve patient health, cancer outcomes, and satisfaction.
Susan F. Dent, MD, will serve as co-moderator of a Wednesday session exploring the expanding field of cardio-oncology and potential cardiovascular toxicities that come with many cancer treatments.
Kimberly J. Van Zee, MS, MD, FACS, previews her presentation looking at ongoing efforts to tailor treatment for ductal carcinoma in situ (DCIS).
Alexandra Thomas, MD, FACP, talks about her presentation on tumor dormancy and late recurrence and the implications for clinical care in breast cancer.
Welcome to the 2022 San Antonio Breast Cancer Symposium and what promises to be an important and informative week of interaction, communication, and education.
Tara Kaufmann, MD, MSCE; Abbey Kaler, MS, APRN, FNP-C; Christine Hodgdon; and Stephanie Walker, RN, preview their presentations in Tuesday’s “Living with Metastatic Breast Cancer” session.
Katharine Yao, MD, and David Krug, MD, discuss their presentations in Tuesday’s “Local Therapy – Best Breast Practice” session.
Check out Tuesday’s General Session abstract presentations and Spotlight Poster Discussion topics and poster presentations.